Globus Medical (GMED) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Globus Medical Reports Third Quarter 2016 Results
November 8, 2016 4:15 PM ESTAUDUBON, Pa., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the third quarter ended September 30, 2016.
Worldwide sales decreased 1.0% as reported to $135.7 million, or a decrease of 0.7% on a constant currency basisThird quarter net income was $26.2 million, or 19.3% of salesDiluted earnings per share (EPS) were $0.27Non-GAAP diluted EPS were $0.29Non-GAAP adjusted EBITDA (AEBITDA) remained at 37.0% of salesCompany issues new 2016 guidance for sales of $560 millionDavid Paul, Chairman and CEO said,... More
